• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 113081
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 08/07/2021
Event Type  Injury  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported approximately 16 hours into a pediatric continuous renal replacement therapy (crrt) in hemodiafiltration (cvvhdf) mode (connected to extracorporeal membrane oxygenation circuit), with a prismaflex control unit and two (2) units of prismaflex hf20 clotted resulting in a blood loss.The amount of blood loss was not specified.Treatment was restarted two and a half hours later with a new prismaflex hf20.Nine hours into treatment, the filter clotted resulting in an unspecified amount of blood loss.Treatment was restarted again on a new prismaflex hf20.On the following day, reported as seventeen hours into treatment, the filter clotted resulting in an unspecified amount of blood loss.It was reported that the prismaflex control unit generated a malfunction: self-test failure code 2, code 4, and code 6 alarms.The patient required packed red blood cells transfusion for the event.The outcome was not reported.No additional information is available.
 
Manufacturer Narrative
Additional information: h3, h6 and h10.H10: the event history log review of the pressure readings showed that clotting alarms were caused by; oscillations of the access and return pressure due to changes of the flows of the ecmo circuit and the natural progressive increase of the pressure drop along the filter (difference between return and filter pressure) determined by building of protein/lipid deposits in the capillaries.The machine was technically assessed by a qualified local service engineer and found to be working within the specification limits.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - LUND MONITORS
magistratsvagen 16
lund skane lan SE-22 643
SW   SE-22643
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key12507400
MDR Text Key272541117
Report Number9616026-2021-00049
Device Sequence Number1
Product Code KDI
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K110823
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number113081
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/03/2021
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
PRISMAFLEX HF20; PRISMAFLEX HF20
Patient Outcome(s) Required Intervention;
Patient Age2 YR
Patient SexMale
Patient Weight10 KG
-
-